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Abstract
Although great progress in genome-wide association studies (GWAS) has been made, the significant SNP associations
identified by GWAS account for only a few percent of the genetic variance, leading many to question where and how we
can find the missing heritability. There is increasing interest in genome-wide interaction analysis as a possible source of
finding heritability unexplained by current GWAS. However, the existing statistics for testing interaction have low power for
genome-wide interaction analysis. To meet challenges raised by genome-wide interactional analysis, we have developed a
novel statistic for testing interaction between two loci (either linked or unlinked). The null distribution and the type I error
rates of the new statistic for testing interaction are validated using simulations. Extensive power studies show that the
developed statistic has much higher power to detect interaction than classical logistic regression. The results identified 44
and 211 pairs of SNPs showing significant evidence of interactions with FDR,0.001 and 0.001,FDR,0.003, respectively,
which were seen in two independent studies of psoriasis. These included five interacting pairs of SNPs in genes LST1/NCR3,
CXCR5/BCL9L, and GLS2, some of which were located in the target sites of miR-324-3p, miR-433, and miR-382, as well as 15
pairs of interacting SNPs that had nonsynonymous substitutions. Our results demonstrated that genome-wide interaction
analysis is a valuable tool for finding remaining missing heritability unexplained by the current GWAS, and the developed
novel statistic is able to search significant interaction between SNPs across the genome. Real data analysis showed that the
results of genome-wide interaction analysis can be replicated in two independent studies.
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Introduction
In the past three years, about 400 genome-wide association
studies (GWAS) that focused largely on individually testing the
associations of single SNP with diseases have been conducted [1].
These studies have identified more than 531 SNPs associated with
different traits or diseases [2] and have provided substantial
information for understanding disease mechanisms. Despite the
progress that has been made, the significant SNP associations
identified by GWAS account for only a few percent of the genetic
variance which begs the question where and how the missing
heritability can be identified [3,4]. Possible explanations include
[1,4]:
(1) The previous GWAS are mainly based on the common
disease, common variant hypothesis. However, in addition to
single nucleotide polymorphisms (SNPs) with a minor allele
frequency (MAF) greater than 1%, there are other classes of
human genetic variation including: (a) rare variants that are
defined as mutations with a MAF of less than 1% and (b)
structural variants including copy number variants (CNVs)
and copy neutral variation such as inversions and transloca-
tions. Common diseases can also be caused by multiple rare
mutations, each with a low marginal genetic effect. A more
realistic model is that the entire spectrum of genetic variants
ranging from rare to common contributes to disease
susceptibility.
(2) Most of current GWAS have focused on SNP analysis in
which each variant is tested for association individually.
However, common disease often arises from the combined
effect of multiple loci within a gene or interaction of multiple
genes within a pathway. If we only consider the most
significant SNPs, the genetic variants that jointly have
significant impact on risk, but individually make only a small
contribution, will be missed.
(3) The power of the widely used statistics for detection of gene-
gene interaction and gene-environment interactions is low.
Many interacting SNPs have not been identified.
Another way to discover the missing heritability of complex
diseases is to investigate gene-gene and gene-environment
interaction. Disease development is a dynamic process of gene-
gene and gene-environment interactions within a complex
biological system which is organized into interacting networks
[5]. Modern complexity theory assumes that the complexity is
attributed to the interactions among the components of the system,
therefore, interaction has been considered as a sensible measure of
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between the components there are, the more complex the system
is. The disease may be caused by joint action of multiple loci.
Motivation for studying statistical interaction is to provide
increased power for detecting joint acting effects of interacting
loci than testing for only marginal association of each of the loci
individually. Screening for only main effects might miss the vast
majority of the genetic variants that interact with each other and
with environment to cause diseases [6]. We argue that the
interactions hold a key for dissecting the genetic structure of
complex diseases and elucidating the biological and biochemical
pathway underlying the diseases [7,8]. Ignoring gene-gene and
gene-environment interactions will likely obscure the detection of
genetic effects and may lead to inconsistent association results
across studies [9,10].
GWAS in which several hundred thousands or even a millions
of SNPs are typed in thousands of individuals provide unprece-
dented opportunities for systematic exploration of the universe of
variants and interactions in the entire genome and also raise
several serious challenges for genome-wide interaction analysis.
The first challenge comes from the problems imposed by multiple
testing. Even for investigating pair-wise interaction, the total
number of tests for interaction between all possible SNPs across
the genome will be extremely large. Bonferroni-corrected P-values
for ensuring genome-wide significance level of 0.05 will be too
small to reach. The second challenge is the need for computa-
tionally simple statistics for testing interactions. The simplest way
to search for interactions between two loci is to test all possible
two-locus interactions. This exhaustive search demands large
computations. Therefore, the computational time of each two-
locus interaction test should be short. The third challenge is the
power of the statistics for testing interaction. To ensure the
genome-wide significance, the statistics should have high power to
detect interaction. Developing simple and efficient analytic
methods for evaluation of the gene-gene interactions is critical to
the success of genome-wide gene-gene interaction analysis. Finally,
the fourth challenge is replication of the finding of such
interactions in independent studies.
This report will attempt to meet these challenges, at least in part.
To achieve this, we first should define a good measure of gene-gene
interaction. Despite current enthusiasm for investigation of gene-
gene interactions, published results that document these interac-
tions in humans are limited and the essential issue of how to define
and detect gene-gene interactions remains unresolved. Over the last
three decades, epidemiologists have debated intensely about how to
define and measure interaction in epidemiologic studies [7,8,11–
15]; The concept of gene-gene interactions is often used, but rarely
specified with precision [16]. In general, statistical gene-gene
interaction is defined as departure from additive or multiplicative
joint effects of the genetic risk factors [17]. It is increasingly
recognized that statistical interactions are scale dependent [18]. In
other words, how to define the effects of a risk factor and how to
measure departure from the independence of effects will greatly
affect assessment of gene-gene interaction. The most popular scale
uponwhichriskfactorsaremeasuredincase-controlstudiesisodds-
ratio. The traditional odds-ratio is defined in terms of genotypes at
two loci. Similar to two-locus association analysis where only
genotype information at two loci is used, odds-ratio defined by
genotypes for testing interaction will not employ allelic association
information. However, it is knownthat interactionbetweentwo loci
will generate allelic associations in some circumstances [19]. Since
they do not use allelic association information between two loci, the
statistical methods based on the odds-ratio that is defined in terms
of genotypes will have less power to detect interaction. To
overcome this limitation, we will define odds-ratio in terms of a
pseudohaplotype (which is defined as two alleles located on the
same paternal or maternal chromosomes) for measuring interac-
tion, and then we will investigate its properties and develop a
statistic based on pseudohaplotype defined odds-ratio for testing
interaction between two loci (either linked or unlinked).
To demonstrate that the pseudohaplotype odds-ratio interaction
measure-based statistic for detection of interaction between two loci
willnot cause false positiveproblems,wetheninvestigate type I error
rates. To reveal the merit and limitation of the pseudohaplotype
odds-ratio interaction measure-based statistic for detection of
interaction, we will compare its power for detecting interaction with
the traditional logistic regression and ‘‘fast-epistasis’’ in PLINK [20].
Although nearly 400 GWAS have been documented, few
genome-wide interaction analyses have been performed and few
findings of significant interaction reported [8,21,22]. Emily et al
[23] tested about 3,107,904–3,850,339 pairs of SNPs located in
genes with potential protein-protein interaction and reported four
significant cases of interactions, one in each of Crohn’s Disease,
bipolar disorder, hypertension and rheumatoid arthritis in the
WTCCC dataset, but these have not been replicated. To further
evaluate the performance of our new statistic and test the
feasibility of genome-wide interaction analysis, the presented
statistic was applied to interaction analysis of two independent
GWAS datasets of psoriasis where 1,266,378,301 pairs of SNPs
from 50,327 SNPs in the first dataset and 1,243,782,750 pairs of
SNPs from 49,876 SNPs in the second dataset were tested for
interactions. These SNPs in the datasets were selected from 501
pathways assembled from KEGG [24] and Biocarta (http://www.
biocarta.com) pathway databases. A program for using the
developed statistic to test interaction which was implemented by
C++ can be downloaded from our website http://www.sph.uth.
tmc.edu/hgc/faculty/xiong/index.htm.
Methods
A case-control study design for detection of interaction between
two loci (SNPs) where two loci can be either linked or unlinked
Author Summary
It is expected that genome-wide interaction analysis can
be a possible source of finding heritability unexplained by
current GWAS. However, the existing statistics for testing
interaction have low power for genome-wide interaction
analysis. To meet challenges raised by genome-wide
interactional analysis, we develop a novel statistic for
testing interaction between two loci (either linked or
unlinked) and validate the null distribution and the type I
error rates of the new statistic through simulations. By
extensive power studies we show that the developed
novel statistic has much higher power to detect interaction
than the classical logistic regression. To provide evidence
of gene–gene interactions as a possible source of the
missing heritability unexplained by the current GWAS, we
performed the genome-wide interaction analysis of
psoriasis in two independent studies. The preliminary
results identified 44 and 211 pairs of SNPs showing
significant evidence of interactions with FDR,0.001 and
0.001,FDR,0.003, respectively, which were common in
two independent studies. These included five interacting
pairs of SNPs, some of which were located in the target
sites: LST1/NCR3, CXCR5/BCL9L and GLS2 of miR-324-3p,
miR-433, and miR-382, and 15 pairs of interacting SNPs
that had nonsynonymous substitutions.
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motivated by the measure of interaction. The widely used logistic
regression methods for detection of gene-gene interaction are
based on then odds-ratio measure of interaction. Traditional
additive and multiplicative odds ratio measures of interaction are
defined in terms of genotypes at two loci. In this report, a novel
statistic for testing interaction between two loci is based on
multiplicative odds-ratio measures defined in terms of pseudoha-
plotypes. For the convenience of presentation, we first briefly
introduce the odds ratio interaction measure in terms of
genotypes, alleles, and then present the odds ratio measure in
terms of pseudohaplotypes.
Genotype-Based Odds Ratio Multiplicative Interaction
Measure
Consider two loci: G and H. Assume that the codes
G~1(G~0) and H~1(H~0) denote whether an individual is
a carrier (non-carrier) of the susceptible genotypes at the loci G
and H, respectively. Let D denote disease status where
D~1(D~0) indicates an affected (unaffected) individual. Con-
sider the following logistic model:
PD ~1DG,H ðÞ ~
eazbGGzbHHzbGHGH
1zeazbGGzbHHzbGHGH : ð1Þ
The odds-ratio associated with G for nonsusceptible genotype at
the locus H (H~0) is defined as
ORG~
P(D~1DG~1,H~0)=P(D~0DG~1,H~0)
P(D~1DG~0,H~0)=P(D~0DG~0,H~0)
:
Similarly, the odds-ratio associated with H for nonsusceptible
genotype at the locus G (G~0) is defined as
ORH~
P(D~1DG~0,H~1)=P(D~0DG~0,H~1)
P(D~1DG~0,H~0)=P(D~0DG~0,H~0)
:
The odds-ratio associated with susceptibility at G and H compared
to the baseline category G~0 and H~0 is then computed as
ORGH~
P(D~1DG~1,H~1)=P(D~0DG~1,H~1)
P(D~1DG~0,H~0)=P(D~0DG~0,H~0)
:
The odds for baseline category G~0 and H~0 are determined as
ORb~
P(D~1DG~0,H~0)
P(D~0DG~0,H~0)
:
From equation (1), we clearly have
ORb~ea,ORG~ebG,ORH~ebH and ORGH~ORGORHebGH:
Define a multiplicative interaction measure between two loci G
and H as
IGH~log
ORGH
ORGORH
: ð2   AÞ
It is clear that
bGH~IGH: ð2   BÞ
If ORGH~ORGORH, i.e., there is no interaction between loci G
and H, then IGH~0. This shows that the logistic regression
coefficient for interaction term bGH is equivalent to the interaction
measure defined as log odds-ratio. The interaction measure IGH
can also be written as
IGH~log
P(G~1,H~1jD~1)P(G~0,H~0jD~1)
P(G~1,H~0jD~1)P(G~0,H~1jD~1)
{
log
P(G~1,H~1jD~0)P(G~0,H~0jD~0)
P(G~1,H~0jD~0)P(G~0,H~1jD~0)
:
The values of odds-ratio defined in terms of genotypes depends on
how to code indicator variables G and H. Suppose that alleles G1
and H1 are alleles that increase disease risk. For a recessive model,
G is coded as 1 if the genotype is G1G1, otherwise, G is coded as 0.
For a dominant model, G is coded as 1 if the genotypes are either
G1G1 or G1G2, otherwise G is coded as 0. The indicator variable
H can be similarly coded. However, in real data analysis, the
disease models are unknown. Especially, the types of two-locus
disease models are large [25]. We may have a large number of
possible coding, and many of them may have larger numbers of
degrees of freedom than the allelic model.
Allele-Based Odds Ratio Multiplicative Interaction
Measure
Similar to the odds ratio for genotypes, we can define odds-ratio
in terms of alleles. Let P(D~1DGi,Hj) be the probability that an
individual becomes affected given they have genotype Gi=Gk at
locus G and Hj=HI at locus H, where Gk is either G1 or G2 (i.e. Gk
is a member of the set {G1,G2}) and HI is either H1 or H2 (i.e. HI
is a member of the set {H1,H2}). We can similarly define
P(D~0DGi,Hj). We then can determine the odds-ratio associated
with the allele G1 at the G locus and allele H1 at the H locus
compared to the baseline G2=H2 as
ORG1=H1~
P(D~1DG1,H1)
P(D~0DG1,H1)
P(D~1DG2,H2)
P(D~0DG2,H2)
:
Similarly, we measure the odds-ratio associated with the alleles
G1=H2 and G2=H1, respectively as
ORG1=H2~
P(D~1DG1,H2)
P(D~0DG1,H2)
P(D~1DG2,H2)
P(D~0DG2,H2)
and ORG2=H1~
P(D~1DG2,H1)
P(D~0DG2,H1)
P(D~1DG2,H2)
P(D~0DG2,H2)
:
Similar to genotype, we can define a multiplicative interaction
measure in terms of log odds-ratio for allele as
IG=H~log
ORG1=H1
ORG1=H2ORG2=H1
which is equivalent to
IG=H~log(R){log(S), where
R~
P(G1,H1jD~1)P(G2,H2jD~1)
P(G1,H2jD~1)P(G2,H1jD~1)
and
S~
P(G1,H1jD~0)P(G2,H2jD~0)
P(G1,H2jD~0)P(G2,H1jD~0)
:
Genome-Wide Interaction Analysis
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harvard.edu/,purcell/plink/index.shtml) is defined as
Z~
log(R){log(S)
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
SE(R)zSE(S)
p ,
where SE(R) and SE(S) denote the standard deviation of R and S,
respectively. Absence of interaction is implied if and only if
P(G1,H1DD~1)P(G2,H2DD~1)
P(G1,H2DD~1)P(G2,H1DD~1)
~
P(G1,H1DD~0)P(G2,H2DD~0)
P(G1,H2DD~0)P(G2,H1DD~0)
:
This is the basis of the ‘‘fast-epistasis’’ test in PLINK.
Haplotype-Based Odds Ratio Multiplicative Interaction
Measure
Suppose that the locus G has two alleles G1 and G2 and the
locus H has two alleles H1 and H2. Let PA
G1,PA
G2,PA
H1,PA
H2 and
PN
G1,PN
G2,PN
H1,PN
H2 be the frequencies of the alleles G1,G2,H1,H2 in
the cases and controls, respectively. For the discussion of
convenience, we introduce a terminology of ‘‘pseudohaplotype’’.
When two loci are linked, a pseudohaplotype is defined as the
regular haplotype. When two loci are unlinked, a pseudohaplotype
is defined as a set of alleles that are located in the same paternal or
maternal chromosomes. The frequencies of a pseudohaplotype
can be estimated by the classical methods for estimation of
haplotype frequencies such as Expectation Maximization (EM)
Algorithms. For simplicity, hereafter we will not make distinction
between the haplotype and pseudohaplotype. When two loci are
unlinked, a haplotype is understood as a pseudohaplotype. Let
PA
11,PA
12,PA
21, PA
22 and PN
11,PN
12,PN
21, PN
22 denote the frequencies of
haplotypes G1H1,G1H2,G2H1 and G2H2 in the cases and controls,
respectively. We define a penetrance of the haplotype GiHj as the
probability that an individual becomes affected given they have
phased genotype GiHj=GkHl,k~1,2,l~1,2. Let fijkl be the
penetrance of an individual with the genotype GiHj=GkHl,
h11,h12,h21 and h22 be the penetrance of the haplotypes
G1H1,G1H2,G2H1 and G2H2, respectively. The penetrance of
the haplotype GiHj can be mathematically defined as
hij~P11fij11zP12fij12zP21fij21zP22fij22,
where P11,P12,P21 and P22 are the population frequencies of the
haplotypes G1H1,G1H2,G2H1 and G2H2, respectively.
G~i and H~j represent a genotype coding scheme. Their
represented genotypes depend on the specific genotype coding
scheme. It should be noted that the haplotype GiHj and G~i and
H~j have different meanings. By the same idea in defining
genotype-based odds ratio in terms of penetrance of combinations
of genotypes, we can determine the odds-ratio associated with the
haplotypes G1H1 compared to the baseline haplotype G2H2 in
terms of penetrance of the haplotypes as
ORG1H1~
h11=(1{h11)
h22=(1{h22)
:
Similarly, we calculate the odds-ratio associated with the
haplotypes G1H2 and G2H1, respectively, as
ORG1H2~
h12=(1{h12)
h22=(1{h22)
and
ORG2H1~
h21=(1{h21)
h22=(1{h22)
:
It is noted that replacing G~i and H~j in the definition of odds-
ratio in terms of genotypes by GiHj leads to the definition of odds-
ratio based on the haplotypes. However, the values and biological
meanings of these two types of odds-ratios are different.
Similar to genotypes, we can compute a multiplicative inter-
action measure in terms of log odds-ratio for haplotypes as
IH
GH~log
ORG1H1
ORG1H2ORG2H1
: ð3Þ
In the absence of interaction, we have
ORG1H1~ORG1H2ORG2H1 or
P(D~1DG1H1)P(D~1DG2H2)
P(D~1DG1H2)P(D~1DG2H1)
~
P(D~0DG1H1)P(D~0DG2H2)
P(D~0DG1H2)P(D~0DG2H1)
:
The multiplicative odds-ratio interaction measure in equation (3) is
defined by the penetrance of the haplotypes. From case-control
data it is difficult to calculate the penetrance of the haplotypes.
However, we can show that the multiplicative odds-ratio
interaction measure in equation (3) can be reduced to (Text S1,
Appendix A)
IH
GH~log
PA
11PA
22
PA
12PA
21
{log
PN
11PN
22
PN
12PN
21
: ð4Þ
There are many algorithms and software to infer the haplotype
frequencies in cases and controls. Therefore, we can easily
calculate the multiplicative odds-ratio interaction measure by
equation (4). It can be seen from equation (4) that the absence of
interaction between two loci occurs if and only if the ratio of
haplotypes frequencies
PA
11PA
22
PA
12PA
21
in the cases and the ratio of
haplotypes frequencies
PN
11PN
22
PN
12PN
21
in the controls are equal.
To gain understanding the multiplicative odds-ratio interaction
measure, we study several special cases.
Case 1. One of two loci is a marker. If we assume that the
locus H is a marker and is not associated with disease, then we
have
PA
ij~P(GiDD~1)P(HjDGi) and PN
ij ~P(GiDD~0)P(HjDGi),
which implies that
PA
11PA
22
PA
12PA
21
~
P(G1DD~1)P(G2DD~1)P(H1DG1)P(H2DG2)
P(G1DD~1)P(G2DD~1)P(H2DG1)P(H1DG2)
~
PN
11PN
22
PN
12PN
21
:
Thus, we obtain IH
GH~0. In other words, if the locus H is a
marker, there is no interaction between two loci G and H. The
Genome-Wide Interaction Analysis
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GH between two loci should be equal to zero.
Hence, our multiplicative odds-ratio interaction measure correctly
characterizes the marker case.
Case 2. Logistic regression interpretation.
We define two indicator variables:
G~
1 G1
0 G2
 
and H~
1 H1
0 H2
 
: ð5Þ
Then four haplotypes at two loci can be coded as follows:
It follows from the logistic regression model in equation (1) that
ORG1H2~ebG~ORG
ORG2H1~ebH~ORH
ORG1H1~ebGzbHzbGH~ORGORHebGH,
where odds-ratios ORG and ORH are defined in terms of alleles,
i.e.
ORG~
P(D~1jG1)=P(D~0jG1)
P(D~1jG2)=P(D~0jG2)
and
ORH~
P(D~1jH1)=P(D~0jH1)
P(D~1jH2)=P(D~0jH2)
Therefore, the haplotype multiplicative odds-ratio interaction
measure IH
GH is equal to IH
GH~bGH, which has the same form as
that in equation (2-B). This indicates that if the coding for the
genotypes in the genotype multiplicative odds-ratio interaction
measure IGH is replaced by the coding for the haplotypes in
equation (5) then we can obtain the haplotype multiplicative odds-
ratio interaction measure.
Test Statistics
In the previous section we defined the haplotype multiplicative
odds-ratio interaction measure, which can be estimated by
haplotype frequencies in cases and controls. By the delta method,
we can obtain the variance of the estimator of the haplotype odds-
ratio interaction measure [26]:
Var(^ I IH
GH)~
1
2nA
1
^ P PA
11
z
1
^ P PA
12
z
1
^ P PA
21
z
1
^ P PA
22
"#
z
1
2nG
1
^ P PN
11
z
1
^ P PN
12
z
1
^ P PN
21
z
1
^ P PN
22
"#
,
where nA and nG are the number of sampled individuals in cases
and controls. By the standard asymptotic theory we can define the
haplotype odds-ratio interaction measure-based statistic for testing
interaction between two loci:
TIH~
^ I IH
GH
   2
V ^ I IH
GH
   ~
log
^ P PA
11^ P PA
22
^ P PA
12^ P PA
21
{log
^ P PN
11^ P PN
22
^ P PN
12^ P PN
21
"# 2
1
2nA
1
^ P PA
11
z
1
^ P PA
12
z
1
^ P PA
21
z
1
^ P PA
22
"#
z
1
2nG
1
^ P PN
11
z
1
^ P PN
12
z
1
^ P PN
21
z
1
^ P PN
22
"#
ð6Þ
where ^ P PA
11,^ P PA
12,^ P PA
21,^ P PA
22 and ^ P PN
11,^ P PN
12,^ P PN
21,^ P PN
22 are the estimators of
the corresponding haplotype frequencies in cases and controls,
respectively. When sample sizes are large enough to ensure
application of large sample theory, TIH is asymptotically
distributed as a central x2
(1) distribution under the null hypothesis
of no interaction between two loci. Under an alternative
hypothesis of of interaction between two loci being present, the
statistic TIH is asymptotically distributed as a noncentral x2
(1)
distribution with noncentrality parameter proportional to the
haplotype multiplicative odds-ratio interaction measure. This
statistic can be applied to both linked and unlinked loci. As we
explained in Text S1, Appendix B, the proposed statistic TIH is
different from the ‘‘fast-epistasis’’ test in PLINK.
For the unlinked loci, we can use case only design [27,28] to
study interaction between two loci in which equation is reduced to
TIH~
log
PA
11PA
22
PA
12PA
21
   2
1
2nA
1
^ P PA
11
z
1
^ P PA
12
z
1
^ P PA
21
z
1
^ P PA
22
"# ð7Þ
Results
Null Distribution of Test Statistics
In the previous sections, we have shown that when the sample
size is large enough to apply large sample theory, the distribution
of the statistic TIH for testing the interaction between two loci
under the null hypothesis of no interaction between them is
asymptotically a central x2
(1) distribution. To examine the validity
of this statement, we performed a series of simulation studies.
MATLAB was used to generate two-locus genotype data of the
sample individuals. A total of 100,000 individuals from a general
population with an allele frequency P(G1)~0:4, P(H1)~0:3,
haplotype frequency P(G1H1)~0:1 and disequilibrium coefficient
d~P(G1H1){P(G1)P(H1)~{0:02 were generated. A total of
10,000 simulations were repeated. Type I error rates were
calculated by random sampling 500–1,000 individuals as cases
and controls from the general population. Table 1 and Table 2
show that the estimated type I error rates of the statistic TIH for
testing interaction between two loci, assuming ORG~ORH~1
and ORG~ORH~2, were not appreciably different from the
nominal levels a~0:05, a~0:01 and a~0:001. To further
examine the validity of the test statistic, we constructed
Quantile-quantile (Q-Q) plots of the test statistic in datasets 1
and 2 shown in Figures 1A and 1B, where the P-values of the tests
were plotted (as 2log10 values) as a function of p values from the
expected null distribution. Since the total number of all possible
pair-wise tests for interaction between SNPs is too large to store all
the results in computer we only stored P-values ,1:00|10{4.
GH
G1H1 11
G1H2 10
G2H1 01
G2H2 00
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showed good agreement with the null distribution.
Power Evaluation
To evaluate the performance of the statistic TIH for detection of
interaction between two loci, we compared the power of the
statistic TIH to that of the logistic model and the ‘‘fast epistasis’’
test in PLINK. Power was calculated by simulation. A total of
1,000,000 individuals from a general population with allele
frequencies P(G1)~0:2, P(H1)~0:3 and P(G1H1)~0:1 and
disequilibrium coefficient d~P(G1H1){P(G1)P(H1)~0:04 were
generated. Two-locus disease models were used to generate cases
and controls, and summarized in Table 3 where odds-ratio was
defined in terms of genotypes. We considered three types of
genotype coding. For a recessive model, homozygous wild type,
heterozygous, and homozygous risk increasing genotypes were
coded as 0, 0, 1, respectively. For a dominant model, homozygous
wild type, heterozygous, and homozygous risk increasing geno-
types were coded as 0, 1, and 1, respectively. For an additive
model, they were coded as 0, 1, and 2, respectively. The genotype
coding for the logistic regression matched the simulation model.
The statistic TIH in equation (6) for the case-control version was
used to evaluate the power. In the power simulations, we also
assumed that ORG~1 and ORH~1. An individual who is
randomly sampled from the general population was assigned to
case or control status depending on the two-locus disease models in
Table 3. The process was repeated until a sample of 1,000 cases
and 1,000 controls for the dominant and additive models, or a
sample of 2,000 cases and 2,000 controls for the recessive model
was obtained. A total of 10,000 simulations were repeated. In
Figures 2A–2C, power comparisons among the logistic regression
model, the ‘‘fast-epistasis’’ in PLINK and the statistic TIH under
two-locus recessive|recessive disease model for significance levels
a~0:05, a~0:01 and a~0:001, respectively are presented. In
Figures 3A–3C, power comparisons among the logistic regression
model, the ‘‘fast-epistasis’’ in PLINK and the statistic TIH under
two-locus dominant|dominant disease model for significance
levels a~0:05, a~0:01 and a~0:001, respectively are shown. In
Figures 4A–4C, power comparisons between the logistic regression
model and the statistic TIH under two-locus additive|additive
disease model for significance levels a~0:05, a~0:01 and
a~0:001, respectively are demonstrated. Several remarkable
features emerge from these Figures. First, these power Figures
indeed demonstrate that the power increases as the measure of the
interaction between two loci increases. The power curves were
plotted as a function of the traditional genotype odds ratio ORGH.
We observed that the power curves were a monotonic increasing
function of the genotype odds ratio ORGH. Therefore, the test
statistic TIH can detect the strength of the interaction between two
loci. Second, the test statistic TIH had much higher power to
detect interaction between two loci than the logistic regression and
the ‘‘fast-epistasis’’ test in PLINK. Third, the more complex the
disease models were, the larger the differences in power between
the test statistic TIH, the ‘‘fast-epistasis’’ test in PLINK and logistic
regression that were observed.
When two loci are unlinked where we do not observe the allelic
association between two loci in the population as a whole, our
results also hold. We assumed the following allele and haplotype
frequencies in the population: P(G1)~0:2, P(H1)~0:3 and
P(G1H1)~0:06. Other parameters were defined as before. A
total of 10,000 simulations were repeated to simulate the power of
three statistics under three disease models with the significance
level a~0:001. Figures 5A, 5B and 5C showed the power of three
statistics for testing interaction between two unlinked loci under
two-locus recessive|recessive, dominant|dominant, and additive
|additive disease models, respectively. These Figures again
demonstrated that the power of the test statistic TIH was still much
higher than that of the logistic regressionand the ‘‘fast-epistasis’’ test
in PLINK. The conclusions still hold for the significance levels
a~0:05 and a~0:01 (Data were not shown).
Application to Pathway-Based Genome-Wide Interaction
Analysis of Psoriasis
To evaluate its performance for detection of interaction between
two loci, the proposed test statistic TIH was applied to interaction
analysis of two independent GWAS datasets of psoriasis which
were downloaded from dbGaP. Psoriasis is a common chronic
inflammatory skin disease affecting 2%–3% of the world
population. Originally, the first study included 955 individuals
with psoriasis and 693 controls, which is considered as dataset 1.
The second replication study included 466 individuals with
psoriasis and 732 controls, which is designated dataset 2. All cases
and controls are of European origin [29–31]. After using PLINK
[20] to check for contamination, cryptic family relationship and
non-Caucasian ancestry, 123 samples were excluded. Subsequent-
ly we retained for analysis 915 cases and 675 controls from the first
study and 431 cases and 702 controls from the second study. All
2,723 samples had been genotyped with the Perlegen 500K array.
In the initial dataset, 451,724 SNPs passed quality control (call
Table 2. Type I error rates of the statistic TIH to test for
interaction between two loci, assuming ORG~ORH~2.
Sample Size Nominal levels
a~ ~0:05 a~ ~0:01 a~ ~0:001
300 0.04990 0.00945 0.00120
400 0.04995 0.01030 0.00085
500 0.05170 0.01065 0.00080
600 0.05070 0.00980 0.00100
700 0.04725 0.00965 0.00113
800 0.04945 0.00895 0.00075
900 0.04830 0.00950 0.00080
1000 0.04920 0.00975 0.00110
doi:10.1371/journal.pgen.1001131.t002
Table 1. Type I error rates of the statistic TIH to test for
interaction between two loci, assuming ORG~ORH~1.
Sample Size Nominal levels
a~ ~0:05 a~ ~0:01 a~ ~0:001
300 0.04790 0.00995 0.00080
400 0.04815 0.00820 0.00080
500 0.04745 0.00930 0.00085
600 0.04880 0.00850 0.00095
700 0.05060 0.00920 0.00075
800 0.05120 0.01015 0.00100
900 0.04935 0.00805 0.00090
1000 0.04860 0.00880 0.00090
doi:10.1371/journal.pgen.1001131.t001
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used PLINK software to remove the SNPs with .5% missing
genotypes, Hardy-Weinberg disequilibrium (P-values ,0.0001),
MAF,0.01 and duplicated markers. In this application, we only
considered common SNPs with MAF.0.01. After quality control
filtering, a total of 451,724 SNPs were pruned to 443,018 and
439,201 SNPs with the average genotyping rate 99.3% in the first
and second studies, respectively.
Since testing for all possible two-locus interactions across the
genome in genome-wide interaction analysis requires extremely
large computation, we conducted pathway-based genome-wide
interaction analysis. We assembled 501 pathways from KEGG
[24] and Biocarta (http://www.biocarta.com). The assignment of
SNPs to a gene was obtained from NCBI human9606 database
(version b129). We used the statistic TIH to test interactions of all
possible pairs of SNPs located in genes within the assembled 501
pathways. The total number of SNPs in dataset 1 and dataset 2
being tested was 50,327 and 49,876, respectively. The serious
problem in genome-wide interaction analysis is multiple testing.
We used two strategies to tackle this problem. One is to use false
discovery rate (FDR) [32] to declare significance of interaction.
Another is replication of the findings in two independent studies,
which enhances confidence in interaction tests [22]. We looked for
consistent results across the two independent studies.
In total, 44 pairs of SNPs showed significant evidence of
interactions with FDR,0.001, which roughly corresponds to the
P-value ,1:0|10{7, in two independent studies (Table S1). These
44 pairs of SNPs were derived from 71 distinct SNPs located in 60
genes, including HLA-C, HLA-DRA, HLA-DPA1, LST1, MICB
and NOTCH4. Of 44 pairs of SNPs, only one pair of interacting
SNPs: rs2395471 and rs2853950 showed significant marginal
association in two independent studies. An additional 211 pairs of
SNPs with FDR less than 0.003 in the two studies is listed in Table
S2. These interacting SNPs were mainly located in 19 pathways,
including a number of signaling pathways, and immune-related
antigen processing and presentation as well as natural killer cell
mediated cytotoxicity pathways (Figure 6). Several remarkable
features emerge from these results. First, although we can observe a
few interactions between SNPs within a gene, the majority of
Figure 1. Quantile-quantile plots for the test statistic TIH. (A) Quantile-quantile plots for the test statistic TIH in dataset 1. The P-values
(,1:0|10{4) for the test are plotted (as 2log10 values) as a function of its expected p values. (B) Quantile-quantile plots for the test statistic TIH in
dataset 2. The P-values (,1:0|10{4) for the test are plotted (as 2log10 values) as a function of its expected p values.
doi:10.1371/journal.pgen.1001131.g001
Table 3. Two-locus disease models.
Recessive| |Recessive
Locus 1\2 D2D2 D2d2 d2d2
D1D1 eaORGORHORGH
1zeaORGORHORGH
eaORG
1zeaORG
eaORG
1zeaORG
D1d1 eaORH
1zeaORH
ea
1zea
ea
1zea
d1d1 eaORH
1zeaORH
ea
1zea
ea
1zea
Dominant| |Dominant
Locus 1\2 D2D2 D2d2 d2d2
D1D1 eaORGORHORGH
1zeaORGORHORGH
eaORGORHORGH
1zeaORGORHORGH
eaORG
1zeaORG
D1d1 eaORGORHORGH
1zeaORGORHORGH
eaORGORHORGH
1zeaORGORHORGH
eaORG
1zeaORG
d1d1 eaORH
1zeaORH
eaORH
1zeaORH
ea
1zea
Additive| |Additive
Locus 1\2 D2D2 D2d2 d2d2
D1D1 eaORG
2ORH
2ORGH
4
1zeaORG
2ORH
2ORGH
4
eaORG
2ORHORGH
2
1zeaORG
2ORHORGH
2
eaORG
2
1zeaORG
2
D1d1 eaORGORH
2ORGH
2
1zeaORGORH
2ORGH
2
eaORGORHORGH
1zeaORGORHORGH
eaORG
1zeaORG
d1d1 eaORH
2
1zeaORH
2
eaORH
1zeaORH
ea
1zea
ea~
p0
1{p0
, p0 is the prevalence of the disease in the population.
The elements in the Table are the penetrance as a function of the joint
genotype at loci 1 and 2 with rows indexing genotype at locus 1 and columns
indexing genotype at locus 2.
doi:10.1371/journal.pgen.1001131.t003
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pathways. Since the number of SNPs typed within each gene was
limited, it is unknown whether this is a general rule or just a special
case. Second, a SNP in one gene might interact with multiple
SNPs in multiple genes. For example, SNP rs3131636 in the gene
MICB interacting with the SNPs rs915895, rs443198, rs3134929 in
the gene NOTCH4, the SNP rs1052248 in the gene LAST1/
Natural cytotoxicity triggering receptor 3 (NCR3) and the SNP
rs1799964 in the gene LTA/TNF. SNP rs1799964 in the gene
LTA/TNF interacting with SNPs rs3131636, rs3132468 in the
gene MICB, SNPs rs9268658 and rs3135392 in the gene HLA-
DRA, SNP rs2227956 in the gene HSPA1L. However, this does
not imply that multiple causal SNPs within a gene will interact with
multiple causal SNPs within another gene. It is quite likely that this
is due to LD between the SNPs within a gene. Third, although
interacting SNPs did not form large connected networks, the
interacting SNPs connected pathways into a large complicated
network. This may imply that many genes and pathways are
involved in the development of psoriasis. Fourth, upstream of many
pathways included genes with interacting SNPs. For example,
Figure 3. Power of the statistics for testing interaction between two linked loci under dominant disease model. (A) The power of the
test statistic TIH, the ‘‘fast-epistasis’’ in PLINK and logistic regression analysis for testing interaction between two linked loci as a function of
traditional odds-ratio ORGH under a two-locus dominant|dominant disease model, where the number of individuals in both the case and control
groups is 1,000, the significance level is 0.05, and the odds-ratios at two loci were ORG~ORH~1. (B) The power of the test statistic TIH, the ‘‘fast-
epistasis’’ in PLINK and logistic regression analysis for testing interaction between two linked loci as a function of traditional odds-ratio ORGH under a
two-locus dominant|dominant disease model, where the number of individuals in both the case and control groups is 1,000, the significance level is
0.01, and the odds-ratios at two loci were ORG~ORH~1. (C) The power of the test statistic TIH, the ‘‘fast-epistasis’’ in PLINK and logistic regression
analysis for testing interaction between two linked loci as a function of traditional odds-ratio ORGH under a two-locus dominant|dominant disease
model, where the number of individuals in both the case and control groups is 1,000, the significance level is 0.001, and the odds-ratios at two loci
were ORG~ORH~1.
doi:10.1371/journal.pgen.1001131.g003
Figure 2. Power of the statistics for testing interaction between two linked loci under recessive disease model. (A) The power of the
test statistic TIH, the ‘‘fast-epistasis’’ in PLINK and logistic regression analysis for testing interaction between two linked loci as a function of
traditional odds-ratio ORGH under a two-locus recessive|recessive disease model, where the number of individuals in both the case and control
groups is 2,000, the significance level is 0.05, and the odds-ratios at two loci were ORG~ORH~1. (B) The power of the test statistic TIH, the ‘‘fast-
epistasis’’ in PLINK and logistic regression analysis for testing interaction between two linked loci as a function of traditional odds-ratio ORGH under a
two-locus recessive|recessive disease model, where the number of individuals in both the case and control groups is 2,000, the significance level is
0.01, and the odds-ratios at two loci were ORG~ORH~1. (C) The power of the test statistic TIH, the ‘‘fast-epistasis’’ in PLINK and logistic regression
analysis for testing interaction between two linked loci as a function of traditional odds-ratio ORGH under a two-locus recessive|recessive disease
model, where the number of individuals in both the case and control groups is 2,000, the significance level is 0.001, and the odds-ratios at two loci
were ORG~ORH~1.
doi:10.1371/journal.pgen.1001131.g002
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EPHB2, LAMA1 and LANA5, ITGA1, LTBP1, TNF, and FGF20
that contain interacting SNPs are in the upstream of natural killer
cell mediated cytotoxicity, calcium signaling pathway, antigen
processing and presentation, axon guidance, ECM-receptor
interaction pathway, focal adhesion, TGFB pathway, MAPK
pathway and regulation of acting cytoskeleton, respectively. Fifth,
mostinteracting SNPsarein intronsand accounted for 77%oftotal
interacting SNPs.
Table 4 listed 15 pairs of interacting SNPs that have non-
synonymous substitutions. It is unknown how these nonsynon-
ymous mutations are involved in the pathogenesis of psoriasis.
From the literature we know that Plexin C1 receptor is a tumor
suppressor gene for melanoma [33], NOTCH4 is involved in
schizophrenia [34], Phosphodiesterase 4D (PDE4D) is associated
with ischemic stroke [35], HLA-DRA is one of the HLA class II
alpha chain genes that plays a central role in antigen processing,
and neuregulin 1 (NRG1) has been implicated in diseases such as
cancer, schizophrenia and bipolar disorder [36].
Table 5 includes five interacting pairs of SNPs, one of which
falls in the microRNA (MiRNA) binding region. miRNAs, which
are 22 nucleotide small RNAs and regulate gene expressions by
Figure 5. Power of the statistics for testing interaction between two unlinked loci. (A) The power of the test statistic TIH, the ‘‘fast-
epistasis’’ in PLINK and logistic regression analysis for testing interaction between two unlinked loci as a function of traditional odds-ratio ORGH
under a two-locus recessive|recessive disease model, where the number of individuals in both the case and control groups is 2,000, the significance
level is 0.001, and the odds-ratios at two loci were ORG~ORH~1. (B) The power of the test statistic TIH, the ‘‘fast-epistasis’’ in PLINK and logistic
regression analysis for testing interaction between two unlinked loci as a function of traditional odds-ratio ORGH under a two-locus
dominant|dominant disease model, where the number of individuals in both the case and control groups is 1,000, the significance level is 0.001,
and the odds-ratios at two loci were ORG~ORH~1. (C) The power of the test statistic TIH, the ‘‘fast-epistasis’’ in PLINK and logistic regression
analysis for testing interaction between two unlinked loci as a function of traditional odds-ratio ORGH under a two-locus additive|additive disease
model, where the number of individuals in both the case and control groups is 1,000, the significance level is 0.001, and the odds-ratios at two loci
were ORG~ORH~1.
doi:10.1371/journal.pgen.1001131.g005
Figure 4. Power of the statistics for testing interaction between two linked loci under additive disease model. (A) The power of the test
statistic TIH, the ‘‘fast-epistasis’’ in PLINK and logistic regression for testing interaction between two linked loci analysis as a function of traditional
odds-ratio ORGH under a two-locus additive|additive disease model, where the number of individuals in both the case and control groups is 1,000,
the significance level is 0.05, and the odds-ratios at two loci were ORG~ORH~1. (B) The power of the test statistic TIH, the ‘‘fast-epistasis’’ in PLINK
and logistic regression for testing interaction between two linked loci analysis as a function of traditional odds-ratio ORGH under a two-locus
additive|additive disease model, where the number of individuals in both the case and control groups is 1,000, the significance level is 0.01, and the
odds-ratios at two loci were ORG~ORH~1. (C) The power of the test statistic TIH, the ‘‘fast-epistasis’’ in PLINK and logistic regression for testing
interaction between two linked loci analysis as a function of traditional odds-ratio ORGH under a two-locus additive|additive disease model, where
the number of individuals in both the case and control groups is 1,000, the significance level is 0.001, and the odds-ratios at two loci were
ORG~ORH~1.
doi:10.1371/journal.pgen.1001131.g004
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implicated in many biological processes including the immune
response, biogenesis and tumorigenesis [37]. Mutations in the
target sites will affect miRNA activity. A number of studies have
identified polymorphisms in the miRNA target sites associated
with the diseases [37]. Interestingly, we identified four SNPs in the
miRNA (miR-324-3p, miR-433, and miR-382) target sites which
interact with five SNPs to contribute to psoriasis. In previous
studies, miR-382 has been associated with dermatomyositis,
Duchenne muscular dystrophy and Miyoshi myopathy [38],
miR-433 and miR-324 with lupus nephritis [39] and miR-433
with Parkinson’s disease [40].
Some researchers suggest that in genome-wide interaction
analysis only SNPs with large or mild marginal genetic effects
should be tested for interaction. To examine whether this strategy
will miss detection of interacting SNPs, we showed in Table 6 the
20 top pairs of interacting SNPs and in Table S3 all pairs of
interacting SNPs with FDR less than 0.003. Surprisingly, 75% of
SNPs with P-values (in dataset 1) larger than 0.2 and 44% of SNPs
with P-values larger than 0.5 in two studies were observed in Table
S3. Table 6 and Table S3 strongly demonstrated that while both
SNPs did not demonstrate significant evidence of marginal
association, they did show significant evidence of interaction.
To further evaluate the performance of the proposed statistic
TIH, in Table 7 and Table S4 we list P-values for testing
interaction calculated by the statistic TIH, the ‘‘fast-epistasis’’ in
PLINK and logistic regression using genotype coding. In Table 7
the 20 top pairs of interacting SNPs and in Table S4 the results of
233 pairs of interacting SNPs are presented. The P-values for
interaction calculated by the statistic TIH are much smaller than
those from the ‘‘fast-epistasis’’ in PLINK and the logistic
regression using genotype coding (Table 7 and Table S4).
Moreover, the ‘‘fast-epistasis’’ in PLINK and the logistic regression
coded by genotype detect very few interactions that can be
replicated in two independent studies (Table 7 and Table S4). In
fact, our results for all tested SNPs in 501 pathways showed that
the ‘‘fast-epistasis’’ in PLINK and logistic regression coded by
genotypes detected very few interactions that can be replicated in
two studies (data not shown).
Eighteen significantly interacting SNPs identified by Bonferroni
correction were listed in Table 8. In dataset1, the total number of
SNPs for testing interaction was 50,327. The P-values for
declaring interaction between SNPs after Bonferroni correction
was 3:95|10{11. We found that there were 2,210 significant
interactions with P-values less than 3:51|10{11 in the dataset 1.
Then, interaction for all these 2,210 pairs of SNPs in the dataset 2
Figure 6. Interacting SNPs that were located in 19 pathways formed a network. Each pathway was represented by an ellipse with the
number. The SNPs were represented by nodes and placed insight their located pathways. Nearby each SNP there was its RS number and the name of
its located gene. The pathway and its harbored SNPs were labeled by the same color. The interacting SNPs were connected by the solid light green
lines.
doi:10.1371/journal.pgen.1001131.g006
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SNPs after Bonferroni correction in dataset 2 was 2:26|10{5.W e
identified eight significant interactions that were replicated in
dataset 2. Similarly, if we started with dataset 2, the total number
of SNPs for testing interaction was 49,876. The P-values for
declaring interaction between SNPs after Bonferroni correction
was 4:02|10{11. Significant interactions with the P-values less
than 3:87|10{11 in dataset 2 were seen between 1,913 pairs of
SNPs. Then, we tested for interaction for all these 1,913 pairs of
SNPs in the dataset 1. The P-values for declaring interaction
between SNPs after Bonferroni correction in dataset 1 was
2:61|10{5, and 10 significant interactions were detected that
were replicated in the dataset 1. A total of 9 interactions were
common in Table 8 and Table S1 and Table S2.
Discussion
The development of most diseases is a dynamic process of gene-
gene and gene-environment interactions within a complex
biological system. We expect that genome-wide interaction
analysis will provide a possible source of finding missing
heritability unexplained by current GWAS that test association
individually. But, in practice, very few genome-wide interaction
analyses have been conducted and few significant interaction
results have been reported. Our aim is to develop statistical
methods and computational algorithms for genome-wide interac-
tion analysis which can be implemented in practice and provide
evidence of gene-gene interaction. The purpose of this report is to
address several issues to achieve this goal.
The first issue is how to define and measure interaction. Odds-
ratio is a widely used measure of interaction for case-control
design. The odds-ratio based measure of interaction between two
loci is often defined as a departure from additive or multiplicative
odds-ratios of both loci defined by genotypes. The genotype-based
odds-ratio does not explore allelic association information between
two loci generated by interaction between them in the cases. Any
statistics that are based on genotype defined odds-ratio will often
have low power to detect interaction. To overcome this limitation,
we extended genotype definition of odds-ratio to haplotypes and
revealed relationships between haplotype-defined odds-ratio and
haplotype formulation of logistic regression. To further examine
the validity of this concept, we studied the distribution of the test
statistic under the null hypothesis of no interaction between two
either linked or unlinked loci. Through extensive simulation
Table 5. Five pairs of interacting SNPs, one of which falls in the microRNA binding region.
SNP1(rs) Gene 1 SNP2(rs) Gene 2 Dataset 1 Dataset 2 MicroRNA Binding Site
P-Value FDR P-Value FDR
1052248 LST1/NCR3 2227956 HSPA1L 8.24E-07 2.17E-03 1.87E-08 4.40E-04 rs1052248 (miR-324-3p)
1052248 LST1/NCR3 3131636 MICB 5.56E-13 3.03E-06 7.76E-10 1.04E-04 rs1052248 (miR-324-3p)
676925 CXCR5/BCL9L 999890 PIP5K3 3.07E-07 1.38E-03 2.93E-07 1.51E-03 rs676925 (miR-382)
163274 ACSM1 2638315 GLS2 8.16E-07 2.16E-03 9.14E-07 2.51E-03 rs2638315 (miR-433)
2072619 MYH11 3822711 GALNT10 1.83E-07 1.09E-03 3.77E-08 6.03E-04 rs3822711 (miR-324-3p)
doi:10.1371/journal.pgen.1001131.t005
Table 4. Interacting SNPs with non-synonymous mutation.
SNP1(rs) Gene1 SNP2(rs) Gene2 Dataset 1 Dataset 2
Nonsynonymous
mutation
Protein
Residue
P-Value FDR P-Value FDR
10837771 OR51B4 16973321 RYR3 1.20E-07 9.00E-04 2.28E-07 1.34E-03 rs10837771 T
7671095 GRID2 10839659 OR2D3 2.00E-08 3.97E-04 2.82E-08 5.29E-04 rs10839659 S
1545133 POLR1B 8064077 MYH11 6.71E-07 1.97E-03 5.88E-07 2.06E-03 rs1545133 L
1958715 OR4L1 3844750 EFNA5 2.15E-08 4.10E-04 1.25E-07 1.03E-03 rs1958715 N
1958716 OR4L1 3844750 EFNA5 4.48E-08 5.73E-04 1.22E-07 1.02E-03 rs1958716 V
2227956 HSPA1L 3135392 HLA-DRA 3.20E-10 6.02E-05 7.82E-10 1.05E-04 rs2227956 M
2227956 HSPA1L 3134929 NOTCH4 7.76E-09 2.57E-04 2.36E-11 2.07E-05 rs2227956 M
1799964 LTA/TNF 2227956 HSPA1L 7.52E-09 2.53E-04 2.98E-08 5.42E-04 rs2227956 M
1052248 LST1/NCR3 2227956 HSPA1L 8.24E-07 2.17E-03 1.87E-08 4.40E-04 rs2227956 M
35258 PDE4D 2230793 IKBKAP 7.50E-08 7.24E-04 7.85E-07 2.34E-03 rs2230793 L
2254524 LSS 10860869 IGF1 8.58E-08 7.70E-04 6.35E-09 2.71E-04 rs2254524 V
327325 NRG1 3742290 UTP14C 7.47E-07 2.07E-03 5.90E-07 2.06E-03 rs3742290 A
4253211 ERCC6 10435892 GABBR2 5.60E-07 1.81E-03 1.11E-09 1.23E-04 rs4253211 P
940389 STON1 10745676 PLXNC1 2.20E-08 4.14E-04 7.02E-07 2.23E-03 rs940389 T
676925 CXCR5 999890 PIP5K3 3.07E-07 1.38E-03 2.93E-07 1.51E-03 rs999890 A
doi:10.1371/journal.pgen.1001131.t004
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distribution of the haplotype odds-ratio-based statistic is close to a
central x2
(1) distribution even for small sample size and that type I
error rates were close to the nominal significance levels.
The second issue is the power of the test statistic for genome-
wide interaction analysis. The genome-wide interaction analysis
requires testing billions of pairs of SNPs for interactions. The P-
values for ensuring genome-wide significance level should be very
small. Therefore, developing statistics with high power to detect
interaction is an essential issue for the success of genome-wide
interaction analysis. As an alternative to the logistic regression and
the ‘‘fast-epistasis’’ in PLINK, we presented a haplotype odds-
ratio-based statistic for detection of interaction between two loci
and illustrated its power by extensive simulations. The power of
the haplotype odds-ratio-based statistic ended up being a function
of the measure of interaction and had much higher power to
detect interaction than the ‘‘fast-epistasis’’ in PLINK and logistic
regression.
The third issue is whether the interactions exist with no
marginal association and how often they might occur in practice.
Our data demonstrated that the majority of the significantly
interacting SNPs showed no marginal association. Surprisingly,
75% of interacting SNPs with P-values (for testing marginal
association) larger than 0.2 and 44% of interacting SNPs with P-
values (for testing marginal association) larger than 0.5 in two
studies were observed in our analysis. This strongly suggested that
testing interaction for only SNPs with strong or mild marginal
association will miss the majority of interactions.
The fourth issue is that of replication of the results. Genome-
wide interaction analysis involves testing billions of pairs of SNPs.
Even if after correction of multiple tests, the false positive results
might be still high. To increase confidence in interaction test
results, replication of interaction findings in independent studies is
often sought. To date, very few results of genome-wide interaction
analysis have been replicated. This begs the question whether the
significant interaction can be replicated in independent studies. In
this report, we show that interaction findings can be replicated in
two independent studies.
The fifth issue is correction for multiple testing. Genome-wide
interaction analysis often involves billions of tests, which would
require an extremely small Bonferroni-corrected P-value to ensure
a genome-wide significance level of 0.05. Replication of finding at
such small P-values in independent studies is often extremely
difficult. However, Bonferroni correction assumes that the tests are
independent, yet many interaction tests are highly correlated.
Correlations in the interaction tests come from two levels [23].
First, two pairs of SNPs may share a common SNP. Second, SNPs
in the interaction tests may be dependent due to allelic association.
The Bonferroni correction assuming independent tests will be
overly conservative due to high correlations among the interaction
tests. In this report, two strategies were used to tackle the multiple
testing issues. The first is to use FDR to control type I error. The
second is to replicate interaction finding. Replication allows us to
detect the interactions that are frequent and consistent [22]. This
approach still has the limitation that we still make independent
assumption of the tests in calculation of FDR. Recently, Emily et
al. (2009) [23] proposed to develop a Bonferroni-like correction for
multiple tests based on the concept of the effective number of SNP
pairs. The concept of the effective number of tests takes correlation
among the tests into account and can be applied to both P-value
Table 6. Top 20 pairs of interacting SNPs.
Association of SNP Interaction
P-value P-value Dataset 1 Dataset 2
SNP1(rs) Dataset 1 Dataset 2 Gene 1 SNP2(rs) Dataset 1 Dataset 2 Gene 2 P-Value FDR P-Value FDR
626072 0.227074 0.053394 LAMA1 6121989 0.862496 0.311346 LAMA5 1.11E-15 1.41E-07 5.67E-07 2.03E-03
626072 0.227074 0.053394 LAMA1 4925386 0.935809 0.264641 LAMA5 1.47E-13 1.73E-06 9.81E-07 2.59E-03
1052248 1.28E-05 0.002907 LST1/NCR3 3131636 0.012961 0.0006472 MICB 5.56E-13 3.03E-06 7.76E-10 1.04E-04
1052248 1.28E-05 0.002907 LST1/NCR3 3132468 0.014008 0.0005969 MICB 8.41E-13 3.70E-06 8.96E-10 1.12E-04
443198 0.000703 2.35E-11 NOTCH4 3131636 0.012961 0.0006472 MICB 1.13E-11 1.24E-05 3.98E-08 6.18E-04
443198 0.000703 2.35E-11 NOTCH4 3132468 0.014008 0.0005969 MICB 1.19E-10 3.76E-05 6.55E-08 7.72E-04
1799964 0.001104 0.009606 LTA/TNF 3131636 0.012961 0.0006472 MICB 1.62E-10 4.35E-05 1.36E-09 1.34E-04
1799964 0.001104 0.009606 LTA/TNF 3132468 0.014008 0.0005969 MICB 2.94E-10 5.80E-05 2.51E-09 1.78E-04
4766587 0.813376 0.391864 ACACB 4807055 0.530091 0.0742653 NDUFA11 3.07E-10 5.90E-05 6.61E-07 2.17E-03
2227956 0.001216 0.000149 HSPA1L 3135392 0.581239 0.75373 HLA-DRA 3.20E-10 6.02E-05 7.82E-10 1.05E-04
1060856 0.824965 0.751351 ALDH7A1 2711288 0.258241 0.0910624 PRKCE 3.57E-10 6.33E-05 2.56E-07 1.42E-03
326346 0.979881 0.212752 CD47 11081513 0.229512 0.79174 VAPA 4.24E-10 6.84E-05 2.81E-07 1.48E-03
1932067 0.043627 0.970441 PAFAH2 13203100 0.208767 0.598145 TIAM2 5.64E-10 7.81E-05 3.04E-08 5.47E-04
2012359 0.369854 0.40799 PARP4 10823333 0.614239 0.882698 HK1 5.65E-10 7.82E-05 7.20E-07 2.25E-03
9311951 0.131357 0.719726 MAGI1 11195879 0.361463 0.072601 NRG3 8.53E-10 9.50E-05 8.25E-07 2.40E-03
3768650 0.318227 0.611621 STAM2 11993811 0.732675 0.862927 FGF20 9.20E-10 9.81E-05 3.25E-08 5.64E-04
785915 0.290127 0.406203 GCNT1 11713331 0.752161 0.621571 PRICKLE2 1.30E-09 1.15E-04 2.95E-07 1.51E-03
785916 0.274961 0.307539 GCNT1 11713331 0.752161 0.621571 PRICKLE2 1.37E-09 1.17E-04 5.51E-07 2.00E-03
1202674 0.254783 0.978976 RPS6KA2 6061796 0.952187 0.932697 CDH4 2.46E-09 1.52E-04 1.63E-08 4.14E-04
1048471 0.414631 0.566854 ST3GAL1 2830096 0.754145 0.728396 APP 2.95E-09 1.65E-04 9.63E-07 2.57E-03
doi:10.1371/journal.pgen.1001131.t006
Genome-Wide Interaction Analysis
PLoS Genetics | www.plosgenetics.org 12 September 2010 | Volume 6 | Issue 9 | e1001131Table 7. P-values of 20 pairs of interacting SNPs calculated by the statistic TIH, PLINK, and logistic regression coded by genotypes.
P-Value
Dataset1 Dataset2
TIH PLINK Logistic Regression TIH PLINK Logistic Regression
rs1 Gene 1 rs2 Gene 2 Recessive Additive Dominant Recessive Additive Dominant
626072 LAMA1 6121989 LAMA5 1.11E-15 1.63E-07 2.61E-02 7.82E-08 3.14E-06 5.67E-07 0.001854 3.65E-02 1.40E-03 1.10E-01
626072 LAMA1 4925386 LAMA5 1.47E-13 1.01E-06 7.64E-02 5.82E-07 1.05E-05 9.81E-07 0.002709 5.07E-02 1.88E-03 1.27E-01
1052248 LST1/NCR3 3131636 MICB 5.56E-13 2.86E-09 8.61E-03 1.14E-09 1.11E-05 7.76E-10 1.76E-05 4.47E-01 9.67E-06 9.75E-06
1052248 LST1/NCR3 3132468 MICB 8.41E-13 4.28E-09 1.16E-02 1.72E-09 1.10E-05 8.96E-10 2.03E-05 4.75E-01 9.97E-06 7.73E-06
443198 NOTCH4 3131636 MICB 1.13E-11 6.14E-08 3.29E-01 2.95E-08 4.53E-05 3.98E-08 6.33E-05 2.93E-02 3.63E-05 7.83E-04
443198 NOTCH4 3132468 MICB 1.19E-10 2.81E-07 3.21E-01 1.52E-07 1.57E-04 6.55E-08 6.32E-05 2.81E-02 4.65E-05 1.39E-03
1799964 LTA/TNF 3131636 MICB 1.62E-10 3.08E-07 7.09E-02 1.52E-07 3.68E-02 1.36E-09 7.26E-05 4.19E-01 3.25E-05 2.59E-06
1799964 LTA/TNF 3132468 MICB 2.94E-10 7.26E-07 9.57E-02 3.80E-07 3.80E-02 2.51E-09 8.30E-05 4.51E-01 4.33E-05 2.76E-06
4766587 ACACB 4807055 NDUFA11 3.07E-10 6.25E-05 3.13E-04 4.84E-05 4.51E-01 6.61E-07 0.000855 3.27E-03 7.74E-04 9.85E-01
2227956 HSPA1L 3135392 HLA-DRA 3.20E-10 2.46E-06 1.14E-04 1.49E-06 2.63E-02 7.82E-10 9.60E-06 7.29E-05 5.17E-06 2.14E-01
1060856 ALDH7A1 2711288 PRKCE 3.57E-10 3.01E-05 1.93E-07 1.71E-05 8.81E-01 2.56E-07 0.000292 7.50E-01 2.09E-04 2.26E-04
2012359 PARP4 10823333 HK1 5.65E-10 3.84E-05 1.26E-04 2.70E-05 1.37E-01 7.20E-07 0.000148 2.06E-04 7.68E-05 1.00E+00
9311951 MAGI1 11195879 NRG3 8.53E-10 6.22E-05 1.00E-03 3.29E-05 3.40E-03 8.25E-07 0.001808 3.81E-02 1.09E-03 1.71E-02
3768650 STAM2 11993811 FGF20 9.20E-10 4.53E-06 8.71E-05 2.52E-06 1.18E-01 3.25E-08 0.000115 1.25E-03 9.91E-05 8.50E-01
785915 GCNT1 11713331 PRICKLE2 1.30E-09 5.34E-05 5.01E-01 3.64E-05 3.37E-04 2.95E-07 3.82E-05 7.13E-05 4.26E-05 3.70E-02
785916 GCNT1 11713331 PRICKLE2 1.37E-09 6.08E-05 5.08E-01 4.21E-05 4.32E-04 5.51E-07 6.98E-05 1.31E-04 8.08E-05 6.61E-02
1202674 RPS6KA2 6061796 CDH4 2.46E-09 4.19E-05 3.78E-01 3.11E-05 1.12E-05 1.63E-08 0.000516 6.48E-03 3.18E-04 7.53E-04
1048471 ST3GAL1 2830096 APP 2.95E-09 2.43E-05 4.55E-04 1.84E-05 1.00E-01 9.63E-07 0.001105 1.11E-01 1.09E-03 3.65E-03
1025951 GALNT13 17568302 FMO2 3.40E-09 3.39E-05 3.16E-03 2.36E-05 2.26E-01 9.29E-07 0.002402 3.30E-03 1.94E-03 1.39E-02
6954 KIAA0467 4773873 ABCC4 3.67E-09 3.30E-06 1.24E-04 2.25E-06 3.11E-03 4.74E-07 0.003416 5.42E-01 1.59E-03 1.36E-02
doi:10.1371/journal.pgen.1001131.t007
Table 8. A total of 18 significantly interacting SNPs identified by Bonferroni Correction.
SNP1 (rs) Gene 1 Chrom 1 Position 1 SNP2 (rs) Gene 2 Chrom 2 Position 2 P-value
Dataset 1 Dataset 2
1052248 LST1/NCR3 6 31664560 3131636 MICB 6 31584073 5.56E-013 7.76E-010
1052248 LST1/NCR3 6 31664560 3132468 MICB 6 31583465 8.41E-013 8.96E-010
443198 NOTCH4 6 32298384 3131636 MICB 6 31584073 1.13E-011 3.98E-008
626072 LAMA1 18 6941189 6121989 LAMA5 20 60350108 1.11E-015 5.67E-007
626072 LAMA1 18 6941189 4925386 LAMA5 20 60354439 1.47E-013 9.81E-007
7113099 NCAM1 11 112409545 10025210 SCD5 4 83858485 2.05E-011 1.00E-005
802509 CNTNAP2 7 145603003 1462140 HPSE2 10 100355999 2.29E-011 1.96E-005
832504 PLXNC1 12 93197019 13222291 KDELR2 7 6483965 2.55E-012 2.19E-005
2227956 HSPA1L 6 31886251 3134929 NOTCH4 6 32300085 7.76E-009 2.36E-011
3129869 HLA-DRA 6 32513649 3177928 HLA-DRA 6 32520413 3.77E-008 5.65E-014
3177928 HLA-DRA 6 32520413 9269080 HLA-DRB4 6 32548947 1.96E-007 3.70E-011
3129882 HLA-DRA 6 32517508 3177928 HLA-DRA 6 32520413 6.96E-007 2.71E-014
2620452 CNTNAP2 7 146644926 16982241 FUT2 19 53894671 1.50E-006 3.48E-012
1479838 CNTNAP2 7 146638597 16982241 FUT2 19 53894671 1.85E-006 1.77E-012
3134929 NOTCH4 6 32300085 3177928 HLA-DRA 6 32520413 2.81E-006 ,1.00E-17
2856993 TAP2 6 32899381 9269080 HLA-DRB4 6 32548947 8.99E-006 1.71E-013
6498575 MYH11 16 15795817 9364864 RPS6KA2 6 166984655 1.14E-005 1.83E-012
935672 PRKCE 2 45899463 2744600 ALDH5A1 6 24641411 2.09E-005 1.88E-011
doi:10.1371/journal.pgen.1001131.t008
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multiple test corrections in the genome-wide interaction analysis.
Although our data show that interactions can partially find the
heritability of complex diseases missed by the current GWAS, they
are still preliminary. Due to extremely intensive computations
demanded by genome-wide interaction analysis we only tested
interactions of a small set of SNPs which were located in the genes
of 501 assembled pathways in a PC computer. The truly whole
genome interaction analysis in which we will test for interactions
between all possible pairs of SNPs across the genome has not been
conducted. Gene-gene interaction is an important, though
complex concept. The statistical interactions are scale dependent.
There are a number of ways to define gene-gene interaction. How
to define gene-gene interaction and develop efficient statistical
methods and computational algorithms for genome-wide interac-
tion analysis are still great challenges facing us. The main purpose
of this report is to stimulate discussion about what are the optimal
strategies for genome-wide interaction analysis. We expect that in
coming years, genome-wide interaction analysis will be one of
major tasks in searching for remaining heritability unexplained by
the current GWAS approach.
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